PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1991 December; 84(12): 714–716.
PMCID: PMC1295516

Breast liver metastases--incidence, diagnosis and outcome.

Abstract

Breast liver metastases are uncommon and have not been well reported. We studied the clinical outcome of 47 patients who developed liver metastases out of 912 breast cancer patients treated between 1982 and 1987, an incidence of 5.2%. The median disease free interval prior to clinical liver metastases was 20.2 months (range 4-192 months). The most frequent clinical presentations were hepatomegaly (70%) and abdominal pain (34%). The diagnosis was confirmed on ultrasound scan in 72.7% patients. Thirty-one patients (70.5%) received specific treatment with both hormone and chemotherapy but only six showed any evidence of objective response, the majority of whom had metastases only in the liver. The median survival of treated patients was 4 months and absence of jaundice, response to treatment and liver metastases only were associated with significantly better survival. In conclusion breast liver metastases usually present as a manifestation of disseminated disease and have an appalling prognosis. When they occur as an initial site the prognosis is better but very few patients overall respond to conventional treatment.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (612K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. [PMC free article] [PubMed]
  • Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981 Jan 1;47(1):207–214. [PubMed]
  • Clark CP, 3rd, Foreman ML, Peters GN, Cheek JH, Sparkman RS. Efficacy of peroperative liver function tests and ultrasound in detecting hepatic metastasis in carcinoma of the breast. Surg Gynecol Obstet. 1988 Dec;167(6):510–514. [PubMed]
  • De Rivas L, Coombes RC, McCready VR, Gazet JC, Ford HT, Neville AM, Powels TJ. Tests for liver metastases in breast cancer: evaluation of liver scan and liver ultrasound. Clin Oncol. 1980 Sep;6(3):225–230. [PubMed]
  • Kamby C. The pattern of metastases in human breast cancer: methodological aspects and influence of prognostic factors. Cancer Treat Rev. 1990 Mar;17(1):37–61. [PubMed]
  • Patanaphan V, Salazar OM, Risco R. Breast cancer: metastatic patterns and their prognosis. South Med J. 1988 Sep;81(9):1109–1112. [PubMed]
  • Zinser JW, Hortobagyi GN, Buzdar AU, Smith TL, Fraschini G. Clinical course of breast cancer patients with liver metastases. J Clin Oncol. 1987 May;5(5):773–782. [PubMed]
  • Kamby C, Dirksen H, Vejborg I, Daugaard S, Guldhammer B, Rossing N, Mouridsen HT. Incidence and methodologic aspects of the occurrence of liver metastases in recurrent breast cancer. Cancer. 1987 Apr 15;59(8):1524–1529. [PubMed]
  • Nemoto T, Dao TL. Significance of liver metastasis in women with disseminated breast cancer undergoing endocrine ablative surgery. Cancer. 1966 Mar;19(3):421–427. [PubMed]
  • Viadana E, Bross ID, Pickren JW. An autopsy study of some routes of dissemination of cancer of the breast. Br J Cancer. 1973 Apr;27(4):336–340. [PMC free article] [PubMed]
  • Smith TJ, Kemeny MM, Sugarbaker PH, Jones AE, Vermess M, Shawker TH, Edwards BK. A prospective study of hepatic imaging in the detection of metastatic disease. Ann Surg. 1982 Apr;195(4):486–491. [PubMed]
  • FENSTER LF, KLATSKIN G. Manifestations of metastatic tumors of the liver. A study of eighty-one patients subjected to needle biopsy. Am J Med. 1961 Aug;31:238–248. [PubMed]
  • Warnes TW. Alkaline phosphatase. Gut. 1972 Nov;13(11):926–937. [PMC free article] [PubMed]
  • Schreve RH, Terpstra OT, Ausema L, Lameris JS, van Seijen AJ, Jeekel J. Detection of liver metastases. A prospective study comparing liver enzymes, scintigraphy, ultrasonography and computed tomography. Br J Surg. 1984 Dec;71(12):947–949. [PubMed]
  • Drum DE, Beard JM. Scintigraphic criteria for hepatic metastases from cancer of the colon and breast. J Nucl Med. 1976 Aug;17(8):677–680. [PubMed]
  • Alderson PO, Adams DF, McNeil BJ, Sanders R, Siegelman SS, Finberg HJ, Hessel SJ, Abrams HL. Computed tomography, ultrasound, and scintigraphy of the liver in patients with colon or breast carcinoma: a prospective comparison. Radiology. 1983 Oct;149(1):225–230. [PubMed]
  • Jaffe BM, Donegan WL, Watson F, Spratt JS., Jr Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet. 1968 Jul;127(1):1–11. [PubMed]
  • Cutler SJ, Ardyce JA, Taylor SG., 3rd Classification of patients with disseminated cancer of the breast. Cancer. 1969 Nov;24(5):861–869. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press